| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |